Cerebral Palsy

Citations

1. Palmer FB, Hoon AH (2011). Cerebral palsy. In M Augustyn et al., eds., The Zuckerman Parker Handbook of Developmental and Behavioral Pediatrics for Primary Care, 3rd ed., pp. 164–171. Philadelphia: Lippincott Williams and Wilkins.

2. Hoon AH Jr, Tolley F (2013). Cerebral palsy. In ML Batshaw et al., eds., Children with Disabilities, 7th ed., pp. 423–450. Baltimore: Paul H Brookes Publishing.

Other Works Consulted

• Ade-Hall RA, Moore AP (2000). Botulinum toxin type A in the treatment of lower limb spasticity in cerebral palsy. Cochrane Database of Systematic Reviews (1). Oxford: Update Software.

• Anttila H, et al. (2008). Effectiveness of physical therapy interventions for children with cerebral palsy: A systematic review. BMC Pediatrics, 8(14): 1–10.

• Ashwal S, et al. (2004). Practice parameter: Diagnostic assessment of the child with cerebral palsy. Neurology, 62(6): 851–863.

• Bernard TJ, et al. (2011). Neurologic and muscular disorders. In WW Hay et al., eds., Current Diagnosis and Treatment: Pediatrics, 20th ed., pp. 696–777. New York: McGraw-Hill.

• Committee on Children with Disabilities, American Academy of Pediatrics (1999, reaffirmed 2010). The treatment of neurologically impaired children using patterning. Pediatrics, 104(5): 1149–1151.

• Delgado MR, et al. (2010). Practice parameter: Pharmacologic treatment of spasticity in children and adolescents with cerebral palsy (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology, 74(4): 336–343.

• Desch LW (2013). Assistive technology. In ML Batshaw et al., eds., Children With Disabilities, 7th ed., pp. 641–656. Baltimore: Paul H Brookes Publishing.

• Diamond M, Armento M (2010). Children with disabilities. In WR Frontera, ed., DeLisa's Physical Medicine and Rehabilitation, vol. 2, pp. 1475–1502. Philadelphia: Lippincott Williams and Wilkins.

• Glader L, Tilton A (2009). Cerebral palsy. In WB Carey et al., eds., Developmental-Behavioral Pediatrics, 4th ed., pp. 653–662. Philadelphia: Saunders Elsevier.

• Hoare BJ, et al. (2010). Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy (Update). Cochrane Database of Systematic Reviews (1).

• Murphy NA, et al. (2008). American Academy of Pediatrics clinical report: Promoting the participation of children with disabilities in sports, recreation, and physical activities. Pediatrics, 121(5): 1057–1061.

• Rapin I (2010). Disorders of motor and mental development. In LP Rowland, TA Pedley, eds., Merritt's Neurology, 12th ed., pp. 568–574. Philadelphia: Lippincott Williams and Wilkins.

• Renshaw TS, Deluca PA (2006). Cerebral palsy. In RT Morrissy, SL Weinstein, eds., Lovell and Winter's Pediatric Orthopaedics, 6th ed., vol. 1, pp. 551–603. Philadelphia: Lippincott Williams and Wilkins.

• Simpson DM, et al. (2008). Assessment: Botulinum neurotoxin for the treatment of spasticity (and evidence-based review): Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology, 70(19): 1691–1698.

© 1995-2011, Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.

This information does not replace the advice of a doctor. Healthwise, Incorporated disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Reference Terms of Use. Reference How this information was developed to help you make better health decisions.